[1] |
Morganti-Kossmann MC,Rancan M,Stahel PF, et al. Inflammatory response in acute traumatic brain injury: a double-edged sword[J]. Curr Opin Crit Care, 2002, 8(2): 101-105.
|
[2] |
夏婧,张玮,钱传云.镇静治疗对ICU危重患者应激的预防作用[J].临床麻醉学杂志, 2009, 25(1): 64-65.
|
[3] |
Stephan H,Sonntag H,Schenk HD, et al. Effect of Disoprivan (propofol) on the circulation and oxygen consumption of the brain and CO2 reactivity of brain vessels in the human[J]. Anaesthesist, 1987, 36(2): 60-65.
|
[4] |
Van Hemelrijck J,Fitch W,Mattheussen M, et al. Effect of propofol on cerebral circulation and autoregulation in the baboon[J]. Anesth Analg, 1990, 71(1): 49-54.
|
[5] |
Oddo M,Steiner LA. Sedation and analgesia in the neurocritical care unit//Smith M,Kofke WA,Citerio G, editors. Oxford textbook of neurocritical care[M]. Oxford: Oxford University Press, 2016.
|
[6] |
Brophy GM,Bell R,Claassen J, et al. Guidelines for the evaluation and management of status epilepticus[J]. Neurocrit Care, 2012, 17(1): 3-23.
|
[7] |
张文坡,张向宁,郭立刚.咪达唑仑在神经外科重症监护病房患者镇静中的应用[J].中国药物与临床, 2015, 15(12): 1793-1794.
|
[8] |
Chamorro C,Borrallo JM,Romera MA, et al. Anesthesia and analgesia protocol during therapeutic hypothermia after cardiac arrest: a systematic review[J]. Anesth Analg, 2010, 110(5): 1328-1335.
|
[9] |
Brummel NE,Girard TD. Preventing delirium in the intensive care unit[J]. Crit Care Clin, 2013, 29(1): 51-65.
|
[10] |
Pohlman AS,Simpson KP,Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study[J]. Crit Care Med, 1994, 22(8): 1241-1247.
|
[11] |
Swart EL,Zuideveld KP,de Jongh J, et al. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients[J]. Br J Clin Pharmacol, 2004, 57(2): 135-145.
|
[12] |
Brajn Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al. Guidelines for the management of severe traumatic brain injury[J]. J Neurotrauma, 2007, 24 Suppl 1: Sl-106.
|
[13] |
Flower O,Hellings S. Sedation in traumatic brain injury[J]. Emer Med Int, 2012, 2012: 637171.
|
[14] |
彭振丽,罗艳丽,赵立昆,等. ICU患者126例镇静镇痛药物应用体会[J].中国现代医药杂志, 2003, 5(5): 52-53.
|
[15] |
Orsini J,Nadkarni A,Chen J, et al. Propofol infusion syndrome: case report and literature review[J]. Am J Health Syst Pharm, 2009, 66(10): 908-915.
|
[16] |
Tanguy M,Seguin P,Laviolle B, et al. Cerebral microdialysis effects of propofol versus midazolam in severe traumatic brain injury[J]. J Neurotrauma, 2012, 29(6): 1105-1110.
|
[17] |
袁绍纪.神经重症患者的镇痛镇静[J].中华神经创伤外科电子杂志, 2015, 1(5): 317-318.
|
[18] |
Brophy GM,Bell R,Claassen J, et al. Guidelines for the evaluation and management of status epilepticus[J]. Neurocrit Care, 2012, 17(1): 3-23.
|
[19] |
Meierkord H,Boon P,Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults[J]. Eur J Neurol, 2010, 17(3): 348-355.
|
[20] |
Beretta L,de Vitis A,Grandi E. Sedation in neurocritical patients: is it useful?[J]. Minerva Anestesiol, 2011, 77(8): 828-834.
|
[21] |
Skoglund K,Enblad P,Marklund N. Monitoring and sedation differences in the management of severe head injury and subarachnoid hemorrhage among neurocritical care centers[J]. J Neurosci Nurs, 2013, 45(6): 360-368.
|
[22] |
Gottschalk A,Yaster M. Pain management after craniotomy[J]. Neurosurg Q, 2007, 17(1): 64-73.
|
[23] |
Kamibayashi T,Maze M. Clinical uses of alpha2-adrenergic agonists[J]. Anesthesiology, 2000, 93(5): 1345-1349.
|
[24] |
容永璋,林华新,莫玉华.右美托咪定对机械通气患者睡眠情况及澹妄发生率的影响[J].国际医药卫生导报, 2013, 19(18): 2858-2861.
|
[25] |
周少丽,谭芳,陈裕洁.右美托咪定用于治疗脓毒症的研究及其进展[J].实用医学杂志, 2013, 29(15): 2421-2422.
|
[26] |
Humble SS,Wilson LD,Leath TC, et al. ICU sedation with dexmedetomidine after severe traumatic brain injury[J]. Brain Inj, 2016: 30(10): 1266-1270.
|
[27] |
郝江,罗积慎,翁奇,等.右美托咪定与异丙酚对颅脑创伤患者β-内啡肽水平的影响及镇静疗效对比研究[J].中华危重病急救医学, 2013, 25(6): 373-376.
|
[28] |
Unlugenc H,Gunduz M,Guler T, et a1. The effect of pre-anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient-controlled morphine[J]. Eur J Anaesthesiol, 2005, 22(5): 386-391.
|
[29] |
Haselman MA. Dexmedetomidine: a useful sdjunct to consider in some high-risk situation[J]. AANA J, 2008, 76(5): 335-339.
|
[30] |
Pajoumand M,Kufera JA,Bonds BW, et al. Dexmedetomidine as an adjunct for sedation in patients with traumatic brain injury[J]. J Trauma Acute Care Surg, 2016, 81(2): 345-351.
|
[31] |
Lai YC,Tsai PS,Huang CJ. Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages[J]. J Surg Res, 2009, 154(2): 212-219.
|
[32] |
周少丽,谭芳,陈裕洁.右美托咪定用于治疗脓毒症的研究及其进展[J].实用医学杂志, 2013, 29(15): 2421-2422.
|
[33] |
安友仲. ICU危重患者的镇痛与镇静[J].医学新知杂志, 2007, 17(5): 252-254.
|
[34] |
安友仲,邱海波,黄青青,等.中国重症加强治疗病房患者镇静和镇痛治疗指导意见[J].中华外科杂志, 2006, 44(17): 1158-1166.
|